Volastra

1 follower


Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and p... Read more

Industries

Employees

51-200

Links


Org chart

Scott Drutman
Head Of R&d And Chief Medical Officer
Collapse
Michael Su
Chief Scientific Officer
Rachel Zolot Schwartz
Chief Business Officer & Head Of Operations
Timothy Bowler
VP Clinical Development
Linda Lee
Senior Director Clinical Science

Board & advisors